UBA1 and laryngotracheoesophageal cleft: Additionally, the abnormal expression of UBA1, an E1 enzyme for ubiquitin-activating enzymes, is associated with lung cancer (LC) (9) and cutaneous squamous cell carcinoma (SCC) (10), revealing the potential value of UBA1 as an HCC diagnostic and prognostic marker.